Continuous Intravenous Milrinone Therapy in Pediatric Outpatients

Milrinone is a phosphodiesterase 3 inhibitor with both positive inotropic and vasodilator properties. Administered as a continuous infusion, milrinone is indicated for the short-term treatment of patients with acute decompensated heart failure. Despite limited data supporting long-term milrinone the...

Descripción completa

Detalles Bibliográficos
Autores principales: Curley, Michelle, Liebers, Jill, Maynard, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2017
Materias:
Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333726/
https://www.ncbi.nlm.nih.gov/pubmed/28248808
http://dx.doi.org/10.1097/NAN.0000000000000214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333726/
https://www.ncbi.nlm.nih.gov/pubmed/28248808
http://dx.doi.org/10.1097/NAN.0000000000000214

Ejemplares similares